Drug Shortage Report for SANDOSTATIN
| Report ID | 223074 |
| Drug Identification Number | 00839191 |
| Brand name | SANDOSTATIN |
| Common or Proper name | SANDOSTATIN 50UG 1X5 AMPS |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OCTREOTIDE |
| Strength(s) | 50MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS |
| Packaging size | 1 X 5 |
| ATC code | H01CB |
| ATC description | HYPOTHALAMIC HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-08-30 |
| Actual start date | 2024-06-17 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-01 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-10-01 | French | Compare |
| v4 | 2024-10-01 | English | Compare |
| v3 | 2024-08-31 | English | Compare |
| v2 | 2024-03-22 | French | Compare |
| v1 | 2024-03-22 | English | Compare |
Showing 1 to 5 of 5